The AHA, joined by member hospitals and health systems and other national organizations representing hospitals, yesterday filed petitions asking the U.S. Supreme Court to reverse appeals court decisions in two important cases for patients and providers.

The two cases being appealed to the U.S. Supreme Court are:

  • A lawsuit challenging the U.S. Department of Health and Human Services鈥 nearly 30% cut to 2018 and 2019 Medicare outpatient prospective payment system drug payments for certain hospitals participating in the 340B Drug Pricing Program. A district court had sided with the AHA and found that the payment reductions were unlawful. However, last July, two members of the three-judge panel of the U.S. Court of Appeals agreed to overturn that ruling, despite a spirited dissent questioning the majority鈥檚 deference to the government鈥檚 position. View the petition.
  • A lawsuit challenging HHS鈥 payment reductions in the 2019 outpatient payment rule for certain hospital outpatient off-campus provider-based departments. A lower court twice found that HHS exceeded its statutory authority when it reduced these payments. But, in July, a three-judge appeals panel reversed this decision. View the petition.

鈥淚n an era of skyrocketing drug prices, the 340B program has been critical in helping hospitals expand access to comprehensive health services to vulnerable communities, including lifesaving prescription drugs. Many of the important programs and services that the 340B program allows eligible hospitals to provide would otherwise be unavailable. These cuts have resulted in the continued loss of resources during this pandemic, which comes at the worst possible time for patients and communities,鈥 said AHA President and CEO Rick Pollack. 鈥淭he unlawful cuts to hospital outpatient departments directly undercut the clear intent of Congress to protect them because of the many real and crucial differences between them and other sites of care. These hospital outpatient departments are held to higher regulatory standards and are often the only point of access for patients with the most severe chronic conditions, all of whom receive treatment regardless of ability to pay.鈥

In addition, Pollack said AHA 鈥渨ill continue to fight for our patients and communities and have put forward compelling arguments that these cases should be taken up by the Supreme Court. We are hopeful that these unlawful cuts will be overturned so that hospitals and health systems can continue to provide the services people need the most.鈥

For more details, see the AHA press release.

Related News Articles

Headline
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater鈥
Chairperson's File
Public
Advocacy is such an important part of what we do as hospitals and health systems 鈥 and what the AHA does on behalf of our field 鈥 to help ensure that we get鈥
Headline
The AHA June 4 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee in defense of the state鈥檚 340B contract pharmacy law鈥
Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B 鈥渞ebate鈥
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state鈥檚 340B contract pharmacy law鈥
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies鈥 requests to approve their unlawful 340B rebate models. 鈥淭he 340B鈥